Deleted Tweets From Scott Gottlieb, R-D.C.

RT @SecAzar: I spoke to @NCAI1944 today about our work to advance tribal health, address public health challenges such as opioid… https://t.co/NElNsXQWYV

RT @angelicalavito: Flu activity is starting to pick up, CDC says. Here's a map with the latest data: https://t.co/u4WamfMR4x

RT @FDA_MCMi: Roses are red Life is full of uncertainty FDA helps our Nation prepare For public health emergencies #healthpolicyvalentines

RT @FDAMedia: FDA authorizes first interoperable insulin pump intended to allow patients to customize treatment through their ind… https://t.co/VfUcbq5M1u

RT @AAADVWorkshop: KEYNOTE SPEAKER for the #2019AAADV Workshop is Anna Abram, Deputy Commissioner for Policy, Planning, Legislation an… https://t.co/3uWYtgzvAC

RT @FDADeviceInfo: Today, the @US_FDA announced an upcoming General and Plastic Surgery Devices Panel of the Medical Devices Advisory… https://t.co/N4bfNTdI8s

RT @FDATobacco: 2018 National Youth Tobacco Survey Finding: Approximately 5 million middle and high school students currently used… https://t.co/59JthpVNJ8

The CGT pathway is intended to incentivize effective development, efficient review, and importantly, the timely market entry of generics for drugs with inadequate competition. https://t.co/e4GuPVAF6K

FDA issued new draft guidance titled, Competitive Generic Therapies, to help provide even greater clarity to industry about the CGT pathway, including how to apply and when generic drug developers may be eligible for exclusivity. https://t.co/e4GuPVAF6K https://t.co/7BO9BgZXGL

Another is providing guidance on submitting required safety notifications for new dietary ingredients (NDIs), ingredients introduced after DSHEA. These submissions are #FDA’s only opportunity to review the safety of an NDI before they reach consumers https://t.co/ed2ycVR5Hu.

These health fraud products haven't been proven to be safe and effective for diseases and health conditions they claim to treat. They prey on vulnerable populations, cause consumers to waste money on unproven products, and often delay proper medical care https://t.co/2IVt6RghMM https://t.co/yw0Vu527rf

…and our continued efforts to protect public health through enforcement action. Last week we posted letters to 17 companies illegally marketing Alzheimer’s disease products, often sold on websites and social media platforms. Other actions are in the works https://t.co/32K9S2eCFy

As we move forward, we’ll also reinforce important existing activities. This includes collaborative research with industry, academia, and government partners, such as our new Botanical Safety Consortium, which we formed to look at novel ways for using toxicology tools…. https://t.co/By7bZlhPAs

Knowing we don’t have all the answers, we’ll also be holding an open meeting this spring to hear from the public about other steps we might consider for advancing responsible innovation - such as clarifying the scope of permitted ingredients or opening a dialogue on exclusivity.

The legal minds at @fdalawblog return to their literary roots with carefully selected headlines culled from the ranks of B song artists from the 1980s and 1990s. This headline is based on the 1991 classic from the global rock sensation "Naughty By Nature". https://t.co/Ymg68LIF1z

Some believe that modifying DSHEA to add a product listing requirement could improve transparency, promote risk-based regulation and establish a mechanism to easily ID bad actors without overly burdening responsible firms. We look forward to future dialogue on this matter.

Dietary supplements can play an important role in our lives as we strive to stay healthy. With modernization of our oversight, our goal is to preserve consumers’ access to lawful supplements while upholding our obligation to protect the public from unsafe and unlawful products. https://t.co/WxMDjqdcz2

RT @CDCgov: In our second #HowVaccinesWork video, we explore how #vaccines help babies fight infections by strengthening their… https://t.co/VmsxIEOotf

RT @FDATobacco: Smoking is a risk factor for heart disease, cancer, and stroke—the leading 1, 2, and 4 causes of death among women… https://t.co/sMbmYDvIzf

RT @SGottliebFDA: THREAD: Access to affordable insulin is literally a matter of life and death, but insulin list prices regularly inc… https://t.co/z6VMSeaJIC

RT @SecAzar: I spoke to @NCAI1944 today about our work to advance tribal health, address public health challenges such as opioid… https://t.co/NElNsXQWYV

RT @angelicalavito: Flu activity is starting to pick up, CDC says. Here's a map with the latest data: https://t.co/u4WamfMR4x

RT @FDA_MCMi: Roses are red Life is full of uncertainty FDA helps our Nation prepare For public health emergencies #healthpolicyvalentines

RT @FDAMedia: FDA authorizes first interoperable insulin pump intended to allow patients to customize treatment through their ind… https://t.co/VfUcbq5M1u

RT @AAADVWorkshop: KEYNOTE SPEAKER for the #2019AAADV Workshop is Anna Abram, Deputy Commissioner for Policy, Planning, Legislation an… https://t.co/3uWYtgzvAC

RT @FDADeviceInfo: Today, the @US_FDA announced an upcoming General and Plastic Surgery Devices Panel of the Medical Devices Advisory… https://t.co/N4bfNTdI8s

RT @FDATobacco: 2018 National Youth Tobacco Survey Finding: Approximately 5 million middle and high school students currently used… https://t.co/59JthpVNJ8

The CGT pathway is intended to incentivize effective development, efficient review, and importantly, the timely market entry of generics for drugs with inadequate competition. https://t.co/e4GuPVAF6K

FDA issued new draft guidance titled, Competitive Generic Therapies, to help provide even greater clarity to industry about the CGT pathway, including how to apply and when generic drug developers may be eligible for exclusivity. https://t.co/e4GuPVAF6K https://t.co/7BO9BgZXGL

Another is providing guidance on submitting required safety notifications for new dietary ingredients (NDIs), ingredients introduced after DSHEA. These submissions are #FDA’s only opportunity to review the safety of an NDI before they reach consumers https://t.co/ed2ycVR5Hu.

These health fraud products haven't been proven to be safe and effective for diseases and health conditions they claim to treat. They prey on vulnerable populations, cause consumers to waste money on unproven products, and often delay proper medical care https://t.co/2IVt6RghMM https://t.co/yw0Vu527rf

…and our continued efforts to protect public health through enforcement action. Last week we posted letters to 17 companies illegally marketing Alzheimer’s disease products, often sold on websites and social media platforms. Other actions are in the works https://t.co/32K9S2eCFy

As we move forward, we’ll also reinforce important existing activities. This includes collaborative research with industry, academia, and government partners, such as our new Botanical Safety Consortium, which we formed to look at novel ways for using toxicology tools…. https://t.co/By7bZlhPAs

Knowing we don’t have all the answers, we’ll also be holding an open meeting this spring to hear from the public about other steps we might consider for advancing responsible innovation - such as clarifying the scope of permitted ingredients or opening a dialogue on exclusivity.

The legal minds at @fdalawblog return to their literary roots with carefully selected headlines culled from the ranks of B song artists from the 1980s and 1990s. This headline is based on the 1991 classic from the global rock sensation "Naughty By Nature". https://t.co/Ymg68LIF1z

Some believe that modifying DSHEA to add a product listing requirement could improve transparency, promote risk-based regulation and establish a mechanism to easily ID bad actors without overly burdening responsible firms. We look forward to future dialogue on this matter.

Dietary supplements can play an important role in our lives as we strive to stay healthy. With modernization of our oversight, our goal is to preserve consumers’ access to lawful supplements while upholding our obligation to protect the public from unsafe and unlawful products. https://t.co/WxMDjqdcz2

RT @CDCgov: In our second #HowVaccinesWork video, we explore how #vaccines help babies fight infections by strengthening their… https://t.co/VmsxIEOotf

RT @FDATobacco: Smoking is a risk factor for heart disease, cancer, and stroke—the leading 1, 2, and 4 causes of death among women… https://t.co/sMbmYDvIzf

RT @SGottliebFDA: THREAD: Access to affordable insulin is literally a matter of life and death, but insulin list prices regularly inc… https://t.co/z6VMSeaJIC